UTD1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UTD1, covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases [Phase 1, Phase 2]